Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 1A receptor, also known as the 5-HT1A receptor, is a subtype of serotonin (5-hydroxytryptamine, or 5-HT) receptors. It is a G protein-coupled receptor (GPCR) that binds the neurotransmitter serotonin and plays a key role in regulating mood, anxiety, and several other physiological processes. Activation of the human HTR1A gene product regulates dopamine and serotonin levels within the brain—affecting neural activity, mood regulation, behavior modulation, anxiety response, aggression control, appetite regulation, cognition/learning/memory processes—and influences sleep/wake cycles among others. It also induces secretion of hormones such as cortisol, ACTH (adrenocorticotropic hormone), oxytocin (linked to prosocial/anxiolytic effects), prolactin, growth hormone & β‑endorphin.
Agonist or antagonist binding to the 5-HT1A receptor, modulating downstream signaling pathways including adenylate cyclase activity, potassium channel opening, and calcium channel closing.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-hydroxytryptamine receptor 1A (None).